Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-02-20 @ 12:34 PM
Study NCT ID:
NCT01913951
Status:
COMPLETED
Last Update Posted:
2024-05-02
First Post:
2013-07-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-30
First Submit QC Date:
None
Study First Post Date:
2013-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-30
Last Update Post Date:
2024-05-02
Last Update Post Date Type:
ACTUAL